Peptide Products

---

O-304 is a synthetic small-molecule research compound developed to modulate cellular senescence-associated pathways. It acts by influencing DNA damage response, SIRT1 signaling, and collagen synthesis in experimental models of aging. O-304 is used in preclinical studies investigating epigenetic regulation, extracellular matrix remodeling, and molecular mechanisms of cellular longevity.

Methylene Blue is a phenothiazine-derived research compound widely utilized in studies of mitochondrial function, redox biology, and cellular respiration. It acts as an alternative electron carrier in the mitochondrial electron transport chain, facilitating NADH oxidation and ATP production under stress conditions. Methylene Blue is used in preclinical research investigating oxidative metabolism, neuroenergetic regulation, and redox-mediated signaling mechanisms.

SLU-PP-332 is a small-molecule research compound identified as a selective agonist of peroxisome proliferator-activated receptor delta (PPARδ). It enhances fatty acid oxidation, mitochondrial biogenesis, and metabolic efficiency in preclinical models by modulating PPARδ-dependent gene expression. SLU-PP-332 is utilized in metabolic and mitochondrial research examining lipid metabolism, endurance signaling, and energy regulation mechanisms.

Triptorelin is a synthetic decapeptide analog of gonadotropin-releasing hormone (GnRH; pGlu-His-Trp-Ser-Tyr-D-Trp-Leu-Arg-Pro-Gly-NH₂). It binds to the GnRH receptor, initiating Gq/PLC and IP₃–Ca²⁺ signaling cascades that regulate luteinizing and follicle-stimulating hormone release in experimental systems. Triptorelin is used in receptor biology and endocrine regulation research to study hypothalamic–pituitary–gonadal axis modulation.

The Glow Blend combines three research peptides, BPC-157, TB-500, and GHK-Cu, formulated for studies on cellular repair, angiogenesis, and extracellular matrix regulation. BPC-157 is a 15 amino acid gastric peptide fragment that modulates nitric oxide and growth factor pathways. TB-500, a segment of Thymosin Beta-4, influences actin polymerization and tissue remodeling. 

BPC-157 is a research peptide composed of 15 amino acids (Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val), a fragment of the body protection compound found in gastric juice. Experimental data suggest it influences angiogenic and cytoprotective signaling through modulation of nitric oxide pathways, growth factor expression, and extracellular matrix remodeling. These actions make it a useful model for studying molecular repair and regenerative processes under stress conditions.

The Glow Blend combines three research peptides, BPC-157, TB-500, and GHK-Cu, formulated for studies on cellular repair, angiogenesis, and extracellular matrix regulation. BPC-157 is a 15 amino acid gastric peptide fragment that modulates nitric oxide and growth factor pathways. TB-500, a segment of Thymosin Beta-4, influences actin polymerization and tissue remodeling. 

BPC-157 is a research peptide composed of 15 amino acids (Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val), a fragment of the body protection compound found in gastric juice. Experimental data suggest it influences angiogenic and cytoprotective signaling through modulation of nitric oxide pathways, growth factor expression, and extracellular matrix remodeling. 

The Glow Blend combines three research peptides, BPC-157, TB-500, and GHK-Cu, formulated for studies on cellular repair, angiogenesis, and extracellular matrix regulation. BPC-157 is a 15 amino acid gastric peptide fragment that modulates nitric oxide and growth factor pathways. TB-500, a segment of Thymosin Beta-4, influences actin polymerization and tissue remodeling. 

SLU-PP-332 is a small-molecule research compound identified as a selective agonist of peroxisome proliferator-activated receptor delta (PPARδ). It enhances fatty acid oxidation, mitochondrial biogenesis, and metabolic efficiency in preclinical models by modulating PPARδ-dependent gene expression. SLU-PP-332 is utilized in metabolic and mitochondrial research examining lipid metabolism, endurance signaling, and energy regulation mechanisms.

The BPC-157 and TB-500 blend combines two well-characterized research peptides studied for their roles in cellular repair, angiogenesis, and tissue remodeling. BPC-157 is a 15 amino acid gastric peptide fragment that modulates nitric oxide pathways and growth factor signaling. TB-500, a segment of Thymosin Beta-4, regulates actin polymerization and promotes cytoskeletal organization. Together, these peptides are used in preclinical research investigating regenerative biology, wound modulation, and peptide-mediated cellular recovery mechanisms.

The Klow Blend combines four research peptides, BPC-157, TB-500, KPV, and GHK-Cu, formulated for studies on cellular repair, immune modulation, and extracellular matrix regulation. BPC-157 is a 15 amino acid gastric peptide fragment that modulates nitric oxide and growth factor pathways. TB-500, a segment of Thymosin Beta-4, regulates actin polymerization and tissue remodeling. KPV, derived from the C-terminal region of alpha-melanocyte-stimulating hormone, modulates NF-κB and cytokine signaling. GHK-Cu, a copper(II)-complexed tripeptide, influences metalloprotein activity and redox balance. 

BPC-157 is a research peptide composed of 15 amino acids (Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val), a fragment of the body protection compound found in gastric juice. Experimental data suggest it influences angiogenic and cytoprotective signaling through modulation of nitric oxide pathways, growth factor expression, and extracellular matrix remodeling. These actions make it a useful model for studying molecular repair and regenerative processes under stress conditions.

BPC-157 is a research peptide composed of 15 amino acids (Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val), a fragment of the body protection compound found in gastric juice. Experimental data suggest it influences angiogenic and cytoprotective signaling through modulation of nitric oxide pathways, growth factor expression, and extracellular matrix remodeling. These actions make it a useful model for studying molecular repair and regenerative processes under stress conditions.

Tesamorelin and Ipamorelin is a research peptide blend designed to explore synergistic activation of the growth hormone axis through dual receptor mechanisms. Tesamorelin, a stabilized GHRH analog, stimulates cAMP/PKA-mediated GH synthesis, while Ipamorelin acts as a selective ghrelin receptor (GHS-R1a) agonist, triggering calcium-dependent signaling. This combination is utilized in studies examining pituitary receptor cross-talk, pulsatile hormone release, and peptide-mediated endocrine regulation.

PT-141 is a synthetic melanocortin receptor agonist structurally derived from the analog Melanotan II. It binds selectively to MC3R and MC4R, modulating neuropeptide signaling pathways involved in hypothalamic control mechanisms. PT-141 is commonly employed in research focusing on GPCR activation, neuronal signaling, and neuroendocrine modulation.

NAD⁺ (nicotinamide adenine dinucleotide) is an essential cellular coenzyme involved in redox metabolism and energy production across all living systems. It functions as a critical electron carrier by cycling between its oxidized (NAD⁺) and reduced (NADH) states, enabling mitochondrial oxidative phosphorylation and glycolytic energy transfer in experimental models. Beyond its metabolic role, NAD⁺ serves as a required substrate for sirtuins and poly(ADP-ribose) polymerases (PARPs), enzymes involved in DNA repair, gene expression regulation, and cellular stress responses.

PT-141 (Bremelanotide) is a synthetic research peptide derived from alpha-melanocyte-stimulating hormone (α-MSH) and engineered for enhanced stability and receptor selectivity. It functions as an agonist of melanocortin receptors, primarily MC4R and MC1R, activating central melanocortin signaling pathways involved in neuroendocrine regulation, autonomic response modulation, and immune-related signaling in experimental models. 

CJC-1295 (no DAC) and Ipamorelin is a research peptide blend combining two mechanistically distinct secretagogues that act synergistically on the growth hormone axis. CJC-1295 (Mod GRF 1–29) targets GHRH receptors, stimulating cAMP/PKA-mediated GH synthesis, while Ipamorelin binds the ghrelin receptor (GHS-R1a), activating Gq/11-linked calcium signaling pathways. Together, they serve as a model for studying peptide-induced GH pulsatility, receptor cross-talk, and hypothalamic–pituitary regulation in controlled experimental systems.

The BPC-157 and TB-500 blend combines two well-characterized research peptides studied for their roles in cellular repair, angiogenesis, and tissue remodeling. BPC-157 is a 15 amino acid gastric peptide fragment that modulates nitric oxide pathways and growth factor signaling. TB-500, a segment of Thymosin Beta-4, regulates actin polymerization and promotes cytoskeletal organization. Together, these peptides are used in preclinical research investigating regenerative biology, wound modulation, and peptide-mediated cellular recovery mechanisms.

TB-500 (Thymosin Beta-4) is a research peptide corresponding to a 43–amino acid sequence of Thymosin Beta-4, an actin-binding protein involved in cytoskeletal organization and tissue regeneration. Preclinical studies demonstrate that TB-500 regulates cell migration, angiogenesis, and actin polymerization through modulation of the β-actin/G-actin cycle and related growth factor signaling. It serves as a model compound for studying wound repair, cellular motility, and peptide-mediated regenerative processes.

TB-500 Fragment (17-23) is a research peptide consisting of a short amino acid sequence derived from the actin-binding region of Thymosin Beta-4. It has been shown in preclinical studies to regulate cell migration, angiogenesis, and cytoskeletal organization through modulation of actin polymerization. This fragment is used in experimental research investigating wound repair, tissue remodeling, and peptide-mediated regenerative signaling mechanisms.

AOD-9604 is a research peptide consisting of amino acids 177–191 of the human growth hormone sequence. Studies indicate it modulates lipid and glucose metabolism pathways without influencing IGF-1 activity, acting primarily through β-adrenergic and AMPK-related mechanisms. It is commonly used in metabolic and adipocyte differentiation research to elucidate downstream energy regulation signaling.

Epithalon (Epitalon) is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) derived from the natural pineal peptide Epithalamin. It has been shown in experimental models to influence telomerase activation, genomic stability, and circadian regulation through modulation of peptide-mediated transcriptional pathways. Epitalon is utilized in molecular biology and gerontology research examining telomere maintenance, oxidative balance, and cellular longevity mechanisms.

Tesofensine is a synthetic small-molecule research compound classified as a triple monoamine reuptake inhibitor of serotonin, norepinephrine, and dopamine. It modulates central appetite and metabolic signaling through presynaptic transporter inhibition and hypothalamic regulation in experimental models. Tesofensine is used in neuroendocrine and metabolic research investigating neurotransmitter dynamics, energy expenditure, and hypothalamic control mechanisms.

GHK-Cu is a research peptide composed of the tripeptide sequence Gly-His-Lys bound to copper(II) ions, forming a biologically active peptide–metal complex studied for its role in extracellular matrix modulation and cellular signaling. Preclinical research indicates that GHK-Cu regulates collagen production, gene expression, and enzymatic antioxidant pathways through copper-mediated redox mechanisms. It serves as a model compound for investigating peptide-driven tissue remodeling, metalloprotein regulation, and regenerative biochemistry.

GHK-Cu is a naturally occurring copper-binding tripeptide (Gly-His-Lys·Cu²⁺) studied for its role in gene expression, extracellular matrix synthesis, and metalloprotein regulation. It forms a high-affinity complex with copper ions that modulates enzymatic catalysis, collagen remodeling, and redox balance in experimental systems. GHK-Cu is widely used in molecular biology and biochemistry research investigating peptide–metal interactions and cellular regenerative mechanisms.

Longevity, Performance & Obesity Research is a research peptide formulation developed to investigate metabolic regulation, mitochondrial function, and nutrient-sensing pathways. Preclinical studies indicate that its components modulate AMPK activation, sirtuin signaling, and oxidative stress response, supporting models of cellular energy balance and redox regulation. This formulation is utilized in experimental research focused on longevity signaling, performance metabolism, and molecular mechanisms of energy efficiency.

NAD⁺ (nicotinamide adenine dinucleotide) is an essential cellular coenzyme involved in redox metabolism and energy production across all living systems. It functions as a critical electron carrier by cycling between its oxidized (NAD⁺) and reduced (NADH) states, enabling mitochondrial oxidative phosphorylation and glycolytic energy transfer in experimental models. Beyond its metabolic role, NAD⁺ serves as a required substrate for sirtuins and poly(ADP-ribose) polymerases (PARPs), enzymes involved in DNA repair, gene expression regulation, and cellular stress responses. 

Gut Inflammation is a research formulation containing stable BPC-157, KPV, palmitoylethanolamide (PEA), and tributyrin designed for studies on intestinal barrier function and inflammatory modulation. Each component contributes to signaling pathways related to epithelial regeneration, cytokine balance, and microbiome–host interaction. This blend is used in preclinical research investigating mucosal peptide regulation and enteric homeostasis mechanisms.